1-16053757-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000085.5(CLCNKB):​c.1741C>T​(p.Leu581Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 1,610,996 control chromosomes in the GnomAD database, including 333,792 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.62 ( 29525 hom., cov: 32)
Exomes 𝑓: 0.64 ( 304267 hom. )

Consequence

CLCNKB
NM_000085.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.515

Publications

19 publications found
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
  • Bartter disease type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Bartter disease type 4B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Gitelman syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-16053757-C-T is Benign according to our data. Variant chr1-16053757-C-T is described in ClinVar as Benign. ClinVar VariationId is 447097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKBNM_000085.5 linkc.1741C>T p.Leu581Leu synonymous_variant Exon 16 of 20 ENST00000375679.9 NP_000076.2 P51801-1A8K8H0
CLCNKBNM_001165945.2 linkc.1234C>T p.Leu412Leu synonymous_variant Exon 9 of 13 NP_001159417.2 P51801-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKBENST00000375679.9 linkc.1741C>T p.Leu581Leu synonymous_variant Exon 16 of 20 1 NM_000085.5 ENSP00000364831.5 P51801-1

Frequencies

GnomAD3 genomes
AF:
0.621
AC:
94109
AN:
151610
Hom.:
29518
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.585
Gnomad AMI
AF:
0.453
Gnomad AMR
AF:
0.535
Gnomad ASJ
AF:
0.550
Gnomad EAS
AF:
0.800
Gnomad SAS
AF:
0.532
Gnomad FIN
AF:
0.719
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.646
Gnomad OTH
AF:
0.605
GnomAD2 exomes
AF:
0.618
AC:
154620
AN:
250188
AF XY:
0.618
show subpopulations
Gnomad AFR exome
AF:
0.577
Gnomad AMR exome
AF:
0.493
Gnomad ASJ exome
AF:
0.559
Gnomad EAS exome
AF:
0.789
Gnomad FIN exome
AF:
0.718
Gnomad NFE exome
AF:
0.644
Gnomad OTH exome
AF:
0.629
GnomAD4 exome
AF:
0.644
AC:
939123
AN:
1459268
Hom.:
304267
Cov.:
72
AF XY:
0.640
AC XY:
464968
AN XY:
725956
show subpopulations
African (AFR)
AF:
0.579
AC:
19361
AN:
33464
American (AMR)
AF:
0.496
AC:
22145
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.564
AC:
14708
AN:
26100
East Asian (EAS)
AF:
0.806
AC:
31984
AN:
39690
South Asian (SAS)
AF:
0.532
AC:
45854
AN:
86182
European-Finnish (FIN)
AF:
0.717
AC:
38097
AN:
53116
Middle Eastern (MID)
AF:
0.569
AC:
3274
AN:
5758
European-Non Finnish (NFE)
AF:
0.654
AC:
725360
AN:
1109960
Other (OTH)
AF:
0.636
AC:
38340
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
19066
38132
57198
76264
95330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19014
38028
57042
76056
95070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.620
AC:
94135
AN:
151728
Hom.:
29525
Cov.:
32
AF XY:
0.619
AC XY:
45920
AN XY:
74134
show subpopulations
African (AFR)
AF:
0.585
AC:
24210
AN:
41408
American (AMR)
AF:
0.534
AC:
8144
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.550
AC:
1907
AN:
3468
East Asian (EAS)
AF:
0.799
AC:
4119
AN:
5152
South Asian (SAS)
AF:
0.531
AC:
2553
AN:
4806
European-Finnish (FIN)
AF:
0.719
AC:
7556
AN:
10504
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.646
AC:
43787
AN:
67826
Other (OTH)
AF:
0.601
AC:
1267
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1744
3487
5231
6974
8718
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
7419
Bravo
AF:
0.605
EpiCase
AF:
0.633
EpiControl
AF:
0.627

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Leu581Leu in exon 16 of CLCNKB: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 78.99% (6785/8590) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs2275167). -

Bartter disease type 3 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bartter disease type 4B Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
14
DANN
Benign
0.84
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.31
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.31
Position offset: -8

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275167; hg19: chr1-16380252; COSMIC: COSV65152867; COSMIC: COSV65152867; API